Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Harrow Return on Tangible Equity 2010-2025 | HROW

Current and historical return on tangible equity values for Harrow (HROW) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Harrow Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.02B $-0.13B 17.87%
2024-12-31 $-0.02B $-0.12B 15.38%
2024-09-30 $-0.03B $-0.13B 31.73%
2024-06-30 $-0.03B $-0.10B 35.48%
2024-03-31 $-0.03B $-0.10B 30.77%
2023-12-31 $-0.02B $-0.09B 21.97%
2023-09-30 $-0.01B $-0.09B 16.28%
2023-06-30 $-0.02B $-0.13B 23.27%
2023-03-31 $-0.02B $-0.13B 45.86%
2022-12-31 $-0.01B $0.00B 162.50%
2022-09-30 $-0.02B $-0.02B 210.00%
2022-06-30 $-0.02B $-0.01B 1314.29%
2022-03-31 $-0.02B $-0.01B -333.33%
2021-12-31 $-0.02B $-0.01B -128.57%
2021-09-30 $-0.01B $0.01B -46.51%
2021-06-30 $0.01B $0.02B 29.47%
2021-03-31 $0.01B $0.03B 45.98%
2020-12-31 $0.00B $0.03B -16.44%
2020-09-30 $0.00B $0.02B -5.48%
2020-06-30 $-0.02B $0.01B -118.31%
2020-03-31 $-0.02B $0.01B -104.55%
2019-12-31 $0.00B $0.03B 3.70%
2019-09-30 $0.02B $0.02B 62.75%
2019-06-30 $0.02B $0.03B 120.00%
2019-03-31 $0.03B $0.03B 236.73%
2018-12-31 $0.01B $0.02B 466.67%
2018-09-30 $-0.01B $0.00B 311.11%
2018-06-30 $-0.01B $0.00B 444.44%
2018-03-31 $-0.01B $-0.01B 800.00%
2017-12-31 $-0.01B $0.00B 5200.00%
2017-09-30 $-0.02B $0.00B -3200.00%
2017-06-30 $-0.01B $0.00B -5600.00%
2017-03-31 $-0.02B $0.00B 8000.00%
2016-12-31 $-0.02B $0.00B -3800.00%
2016-09-30 $-0.02B $0.00B 1200.00%
2016-06-30 $-0.02B $0.00B 1200.00%
2016-03-31 $-0.02B $0.00B 1360.00%
2015-12-31 $-0.02B $-0.01B 1066.67%
2015-09-30 $-0.01B $0.00B -700.00%
2015-06-30 $-0.01B $0.00B -252.63%
2015-03-31 $-0.01B $0.00B -151.72%
2014-12-31 $-0.01B $0.01B -97.56%
2014-09-30 $-0.01B $0.01B -73.47%
2014-06-30 $-0.01B $0.01B -64.29%
2014-03-31 $-0.01B $0.01B -51.61%
2013-12-31 $-0.01B $0.02B -42.42%
2013-09-30 $-0.01B $0.02B -39.34%
2013-06-30 $-0.01B $0.02B -44.44%
2013-03-31 $-0.01B $0.02B -71.43%
2012-12-31 $-0.01B $0.01B -200.00%
2012-06-30 $0.00B 533.33%
2012-03-31 $0.00B 400.00%
2010-09-30 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B -800.00%
2010-03-31 $0.00B $0.00B -400.00%
2009-12-31 $-0.01B $0.00B -285.71%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.121B $0.200B
Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.223B 30.47
Zoetis (ZTS) United States $70.824B 26.42
Takeda Pharmaceutical (TAK) Japan $49.065B 9.76
Daiichi Sankyo, - (DSNKY) Japan $43.191B 22.14
BeOne Medicines - (ONC) Cayman Islands $26.778B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.734B 0.00
Merck (MKKGY) Germany $17.176B 12.59
Summit Therapeutics (SMMT) United States $16.799B 0.00
Shionogi (SGIOY) Japan $15.040B 15.07
United Therapeutics (UTHR) United States $13.316B 11.78
Neurocrine Biosciences (NBIX) United States $12.806B 43.86
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Corcept Therapeutics (CORT) United States $7.565B 61.50
Stevanato Group S.p.A (STVN) Italy $7.414B 45.33
Ionis Pharmaceuticals (IONS) United States $6.938B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.664B 0.00
Grifols, S.A (GRFS) Spain $6.284B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.344B 0.00
Hypermarcas (HYPMY) Brazil $3.180B 20.92
Crinetics Pharmaceuticals (CRNX) United States $2.756B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.623B 14.19
Catalyst Pharmaceuticals (CPRX) United States $2.616B 9.17
NewAmsterdam Pharma (NAMS) Netherlands $2.129B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.887B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.835B 0.00
ARS Pharmaceuticals (SPRY) United States $1.645B 0.00
Endo (NDOI) United States $1.631B 0.00
Evotec AG (EVO) Germany $1.541B 0.00
Ocular Therapeutix (OCUL) United States $1.507B 0.00
Guardian Pharmacy Services (GRDN) United States $1.303B 0.00
Dyne Therapeutics (DYN) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.013B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.012B 20.24
Ardelyx (ARDX) United States $1.002B 0.00
Verve Therapeutics (VERV) United States $0.999B 0.00
Collegium Pharmaceutical (COLL) United States $0.980B 5.29
Akebia Therapeutics (AKBA) United States $0.953B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.852B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Xeris Biopharma Holdings (XERS) United States $0.740B 0.00
Elite Pharmaceuticals (ELTP) United States $0.641B 0.00
Relay Therapeutics (RLAY) United States $0.617B 0.00
USANA Health Sciences (USNA) United States $0.604B 13.14
Xencor (XNCR) United States $0.591B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.586B 0.00
KalVista Pharmaceuticals (KALV) United States $0.586B 0.00
Bioventus (BVS) United States $0.563B 14.27
Theravance Biopharma (TBPH) United States $0.553B 0.00
Zevra Therapeutics (ZVRA) United States $0.515B 0.00
Organogenesis (ORGO) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.477B 9.97
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Tourmaline Bio (TRML) United States $0.416B 0.00
Altimmune (ALT) United States $0.397B 0.00
AleAnna (ANNA) United States $0.391B 0.00
Aquestive Therapeutics (AQST) United States $0.366B 0.00
Savara (SVRA) United States $0.363B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 9.01
Heron Therapeutics (HRTX) United States $0.328B 0.00
Nektar Therapeutics (NKTR) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.280B 25.71
Tonix Pharmaceuticals Holding (TNXP) United States $0.259B 0.00
Aldeyra Therapeutics (ALDX) United States $0.240B 0.00
Liminatus Pharma (LIMN) United States $0.229B 0.00
Esperion Therapeutics (ESPR) United States $0.228B 0.00
OmniAb (OABI) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
MediWound (MDWD) Israel $0.207B 0.00
China SXT Pharmaceuticals (SXTC) China $0.207B 0.00
4D Molecular Therapeutics (FDMT) United States $0.200B 0.00
Larimar Therapeutics (LRMR) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Journey Medical (DERM) United States $0.164B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.157B 0.00
Lexeo Therapeutics (LXEO) United States $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Galectin Therapeutics (GALT) United States $0.137B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Korro Bio (KRRO) United States $0.123B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Nutriband (NTRB) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.115B 0.00
Champions Oncology (CSBR) United States $0.107B 17.66
Protara Therapeutics (TARA) United States $0.107B 0.00
VAXART, INC (VXRT) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Achieve Life Sciences (ACHV) Canada $0.078B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.89
Gain Therapeutics (GANX) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Jupiter Neurosciences (JUNS) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.023B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Ainos (AIMD) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.11
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
ProKidney (PROK) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00